financetom
Business
financetom
/
Business
/
Update: Brookfield Business Partners Q4 Net Loss Narrows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Brookfield Business Partners Q4 Net Loss Narrows
Mar 11, 2026 2:17 AM

07:33 AM EST, 01/30/2026 (MT Newswires) -- Brookfield Business Partners (BBU-UN.TO) reported Friday that fourth-quarter net loss narrowed.

Net income attributable to unitholders for the quarter was US$4 million, or US$0.48 per limited partnership unit, compared with net loss of US$438 million, or US$2.02 per limited partnership unit in the prior year period.

The company said its advanced energy storage operation benefited from the growing demand of higher margin advanced batteries and strong commercial execution. The improved contribution at its engineered components manufacturer was supported by commercial discipline, despite the impact of weak market conditions and reduced volumes, the company said.

Brookfield expects to declare a quarterly dividend of US$0.0625 per share, payable on March 31. Going forward, it expects to pay an annual dividend of $0.25 per share, consistent with the current distribution and dividend paid on BBU units and BBUC exchangeable shares.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Iraq's SOMO sells Qaiyarah crude oil to Valero at deep discount, sources say
Iraq's SOMO sells Qaiyarah crude oil to Valero at deep discount, sources say
Sep 20, 2024
SINGAPORE, Sept 20 (Reuters) - Iraq's SOMO has sold 500,000 barrels of Qaiyarah crude to U.S. refiner Valero Energy ( VLO ) , out of the 2 million barrels it offered via a tender on the S&P Platts Market on Close process late on Thursday, trade sources said. Iraq's offer of prompt-loading Qaiyarah crude comes at a time when Asian...
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate
Sep 20, 2024
4D Molecular Therapeutics ( FDMT ) stock is trading lower on Thursday after the company released interim follow-up data from the Phase 1/2 PRISM clinical trial and 4FRONT Phase 3 study design. Robust and durable treatment burden reduction was observed in all PRISM populations studied with the planned Phase 3 dose of 3E10 vg/eye of 4D-150. 83% overall reduction in...
Trump Media shares face potential sell-off as insider selling restrictions lift
Trump Media shares face potential sell-off as insider selling restrictions lift
Sep 20, 2024
(Reuters) - While former U.S. President Donald Trump has said he will not sell his $1.7 billion stake in Trump Media ( DJT ) after restrictions likely expire on Thursday, other insiders could soon cash in their gains. Trump Media & Technology Group ( DJT ) is 57% owned by the Republican presidential candidate who told reporters last Friday that...
Johnson & Johnson Receives FDA Approval for Non-Small Cell Lung Cancer Treatment
Johnson & Johnson Receives FDA Approval for Non-Small Cell Lung Cancer Treatment
Sep 20, 2024
03:57 AM EDT, 09/20/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said late Thursday the US Food and Drug Administration has approved Rybrevant in combination with chemotherapy for the treatment of adult patients with certain forms of locally advanced or metastatic non-small cell lung cancer. The FDA approval is based on results from a phase 3 study that...
Copyright 2023-2026 - www.financetom.com All Rights Reserved